Article
22 Apr 2025
Trump Administration Issues Executive Order To Lower Prescription Drug Costs
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
20 Feb 2025
A First Look At The MAHA Era: Initial Thoughts For Industry Based On The MAHA Commission EO
Article
18 Feb 2025
The DOGE Workforce Optimization EO: Implications For FDA
Article
30 Jan 2025
FDA Finalizes Rule On ACNU Drugs, Signaling Opening For Next-Gen OTC Drugs
Article
27 Dec 2024
Recent SEC Case Against Biotech Company Highlights The Intersection Between FDA Findings And SEC Enforcement
Article
17 Dec 2024
FDA Issues New Draft Guidance For Expedited Program For Serious Conditions — Accelerated Approval Of Drugs And Biologics
Article
13 Nov 2024
The Convergence Of Life Sciences And Artificial Intelligence: Seizing Opportunities While Managing Risk
Article
15 Jul 2024
FDA Issues Revised Draft Guidance On Addressing Misinformation About Medical Devices And Prescription Drugs
Article
11 Jul 2024
When APA Claims Accrue Under Corner Post: Implications For The Life Sciences Industry
Article
03 Jul 2024
Chevron Overturned: What Does It Mean For Life Sciences Companies?
